High prevalence of loss of Claudin‐18 expression in invasive non‐mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice
Histopathology · 2026-07 · 89 (1) · 81-97
DOI: 10.1111/his.70137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 12.03.2026. Verfasst von Stefano Lucà und 18 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, I…. Hauptthemen laut MEDLINE: Lung Neoplasms, Claudins, Biomarkers, Tumor, Adenocarcinoma of Lung. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Accurate diagnosis of lung adenocarcinoma (LUAD), particularly in small biopsy specimens, can be challenging due to limited tissue availability and the presence of histological mimickers. Claudin‐18 ( Cldn18 ), a tight junction protein with a lung‐specific isoform ( Cldn18.1 ), is normally expressed in alveolar epithelium and is implicated in maintaining alveolar integrity. Loss of Cldn18 has been linked to LUAD development through dysregulated YAP signalling. This study evaluated Cldn18 expression across lung cancer subtypes, with particular focus on LUAD. Methods and results Cldn18 immunohistochemical expression was retrospectively assessed in 391 lung resection specimens and 53 small biopsy samples. Normal alveoli and reactive pneumocytes consistently expressed Cldn18 , whereas LUADs, especially non‐mucinous LUADs (NM‐LUADs), typically showed marked loss. Complete absence of Cldn18 was observed in 83% of NM‐LUAD resections and 84.8% of NM‐LUAD biopsies. ROC analysis demonstrated excellent diagnostic accuracy (AUC 0.992), with sensitivity of 98.4% and specificity of 100%. Lepidic NM‐LUAD components, a frequent diagnostic pitfall especially in small specimens, showed low expression in most cases (>50% of tumour cells in 24/26). Similarly, 6/7 atypical adenomatous hyperplasia (AAH) cases exhibited low expression, while all reactive pneumocyte proliferations retained staining. By contrast, mucinous LUADs (M‐LUADs) preserved Cldn18 expression in 35/54 cases, providing a clear distinction from NM‐LUADs with mucin production.
Conclusions
Cldn18 loss is a promising diagnostic biomarker for NM‐LUAD. Complete loss of Cldn18 expression could serve as an ancillary tool for distinguishing malignant lesions from NM‐LUAD mimickers and for differentiating NM‐LUADs with mucin production from true M‐LUADs, particularly in small or challenging biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, Italy.
- Medical Statistics Unit, Department of Mental and Physical Health and Preventive Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, Italy.
- Radiology Unit, Department of Precision Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, Italy.
- Unit of Surgical Pathology, S. Chiara Hospital, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, Italy.
- Medical Oncology, Department of Precision Medicine, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, Italy.
- Division of Thoracic Surgery, Università Degli Studi Della Campania "Luigi Vanvitelli", Naples, Italy.
ORCID-Profile: Stefano Lucà, Marco Montella, Mario Fordellone, Giuseppa Zannini, Beatrice Leonardi, Valerio Nardone, Floriana Morgillo, Alfonso Fiorelli, Luisella Righi, Mattia Barbareschi, Luka Brcic, Renato Franco
Zitieren
APA
Lucà, S., Montella, M., Fordellone, M., Monti, R., Disanto, M. G., Zannini, G., Accardo, M., Ali, M., Di Guida, G., Della Corte, C. M., Leonardi, B., Campione, S., Nardone, V., Morgillo, F., Fiorelli, A., Righi, L., Barbareschi, M., Brcic, L., & Franco, R. (2026). High prevalence of loss of Claudin‐18 expression in invasive non‐mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice. Histopathology, 89(1), 81-97. https://doi.org/10.1111/his.70137
Vancouver
Lucà S, Montella M, Fordellone M, Monti R, Disanto MG, Zannini G, et al. High prevalence of loss of Claudin‐18 expression in invasive non‐mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice. Histopathology. 2026;89(1):81-97. doi:10.1111/his.70137
BibTeX
@article{Luc2026,
author = {Lucà, Stefano and Montella, Marco and Fordellone, Mario and Monti, Riccardo and Disanto, Maria Giulia and Zannini, Giuseppa and Accardo, Marina and Ali, Maria and Di Guida, Gaetano and Della Corte, Carminia Maria and Leonardi, Beatrice and Campione, Severo and Nardone, Valerio and Morgillo, Floriana and Fiorelli, Alfonso and Righi, Luisella and Barbareschi, Mattia and Brcic, Luka and Franco, Renato},
title = {High prevalence of loss of Claudin‐18 expression in invasive non‐mucinous lung adenocarcinoma: Potential diagnostic implications in routine practice},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {1},
pages = {81--97},
doi = {10.1111/his.70137}
}
EUVIMED